Quantcast

Latest Hematological malignancy Stories

2014-10-20 16:27:17

WHITE PLAINS, N.Y., Oct. 20, 2014 /PRNewswire-USNewswire/ -- Six academic investigators will receive grants from The Leukemia & Lymphoma Society (LLS) to support innovative ideas that that have the potential to take research in a new direction and fundamentally impact the future of blood cancer diagnosis and treatment. The second-year grant program, called The New Idea Award, looks to identify novel research strategies that involve the exploration of untested but potentially...

2014-10-14 12:30:31

NEW BRUNSWICK, N.J., Oct. 14, 2014 /PRNewswire-USNewswire/ -- Actinobac Biomed Inc., has received a $905,040 Small Business Technology Transfer Grant (STTR) Phase II Award from the National Institutes of Health/ National Cancer Institute to continue to develop its drug candidate, Leukothera®, as a potential treatment for B-cell lymphomas. "This NIH grant supports our assertion that Actinobac scientists are working on breakthrough research that can make a tremendous difference for...

2014-10-09 16:27:54

Additional Global Regulatory Filings Reinforce Commitment to Addressing Significant Unmet Needs for Patients With This Aggressive Cancer With Limited Treatment Options THOUSAND OAKS, Calif., Oct. 9, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for the investigational bispecific T cell engager (BiTE(®)) antibody construct, blinatumomab. The BLA is for the...

2014-09-29 08:31:43

Expansion of Collaboration Enables Identification of Optimal Patient Profiles and Combination Strategies for APTO-253 SAN DIEGO, CA AND TORONTO, ON; PORTLAND, OR AND WHITE PLAINS, NY, Sept. 29, 2014 /PRNewswire/ - Aptose Biosciences Inc. (TSX: APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, the Knight Cancer Institute at Oregon Health & Science University (OHSU) and The Leukemia &...

2014-09-22 23:10:40

New survey conducted by CML-IQ highlights need for CML awareness and increased resources for patients. Montreal, Quebec (PRWEB) September 22, 2014 Today has been designated World CML Day to broaden understanding of chronic myelogenous leukemia, a form of blood cancer that affects approximately 5,000 Canadians. In most cases, CML is caused by a mutation affecting chromosomes 22 and 9. So that date – 22/9 – has become a powerful symbol as the worldwide community unites to raise...

2014-09-22 08:29:14

FDA Submission Reinforces Commitment to Addressing Significant Unmet Needs for Patients With Acute Lymphoblastic Leukemia, an Aggressive Cancer With Limited Treatment Options THOUSAND OAKS, Calif., Sept. 22, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval for its investigational bispecific T cell engager (BiTE(®)) antibody construct, blinatumomab. The BLA is...

2014-09-12 23:05:19

North Texas Indoor Trampoline Park to Help Raise Money During the 2014-2015 School Year Frisco, Texas (PRWEB) September 12, 2014 Leukemia, the most common cancer in children under the age of 20 years old, affects about 4,103 school aged children every year in the US alone. For youth and their families, the diagnosis can be both mentally and financially crushing. In an effort to decrease these hardships and incentivize students to raise money for the cause, Urban Air Trampoline Park is...

2014-09-10 12:24:59

Thousands to Walk to Raise Funds for Blood Cancer Research SAN FRANCISCO, Sept. 10, 2014 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society's (LLS) Northern California Chapter will be kicking off its 2014 Light The Night(®) Walk campaign with the San Francisco Walk on September 23, 2014 at 5 p.m. PT at AT&T Park. The Light The Night Walk is a powerful and unique fundraising campaign from LLS, which brings together families and communities to honor blood cancer...

2014-09-03 12:26:23

Leukemia Cup Regatta to Take Place September 20-21 at The San Francisco Yacht Club SAN FRANCISCO, Sept. 3, 2014 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society's (LLS) Greater Bay Area Chapter will be hosting its ninth annual Leukemia Cup Regatta on September 20-21, 2014 at The San Francisco Yacht Club (SFYC) in Belvedere, Calif. The event will begin with the VIP Dinner on September 20 with special guest speaker Wendy Schmidt, president of the Schmidt Family Foundation...

2014-08-28 08:27:53

WHITE PLAINS, N.Y., Aug. 28, 2014 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society (LLS) and OncoPep have entered a partnership to advance an experimental cancer vaccine to treat patients with smoldering multiple myeloma (SMM), an asymptomatic stage of myeloma. The partnership is through LLS's Therapy Acceleration Program® (TAP), through which LLS forges collaborations with biotechnology companies to help bring therapies to patients faster. OncoPep is developing a...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related